找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiopharmaceuticals; A Guide to PET/CT an Ferdinando Calabria,Orazio Schillaci Book 20202nd edition The Editor(s) (if applicable) and The

[復(fù)制鏈接]
樓主: 水平
21#
發(fā)表于 2025-3-25 05:31:00 | 只看該作者
22#
發(fā)表于 2025-3-25 10:40:10 | 只看該作者
Sebastiano Cosentino,Fabrizio Scopelliti,Gabriella Murè,Sara Baldari,Massimo Ippolito
23#
發(fā)表于 2025-3-25 15:09:09 | 只看該作者
Robert Pichler,Johannes Wolfsgruber,Ferdinando Calabria,Orazio Schillaci,Andreas Dunzinger
24#
發(fā)表于 2025-3-25 16:07:40 | 只看該作者
25#
發(fā)表于 2025-3-25 22:42:41 | 只看該作者
18F-DOPA,since the dopamine uptake is reduced in Parkinson’s disease..Neuroendocrine tumors may also show uptake of .F-DOPA: in this field, .F-DOPA PET/CT can be a valid tool in the assessment of primitive tumor or secondary lesions. In recurrent medullary carcinoma of the thyroid, this diagnostic tool has a
26#
發(fā)表于 2025-3-26 01:41:05 | 只看該作者
Lipogenesis Pathway: Radiolabeled Choline,nt behavior but cannot be examined with .F-FDG PET/CT, due to low grade of glucose metabolism expressed: under study is the potential role of radiolabeled choline PET/CT in the management of patients with bladder cancer and bronchioloalveolar and hepatocellular carcinoma..The exact knowledge of the
27#
發(fā)表于 2025-3-26 07:39:26 | 只看該作者
18F-NaF,rheumatoid arthritis, amyloidosis, and lymphomas. Globally, nuclear medicine physicians must take into account the possibility of .F-NaF uptake in all calcifications that can occur in benign or malignant diseases.
28#
發(fā)表于 2025-3-26 08:28:42 | 只看該作者
29#
發(fā)表于 2025-3-26 14:16:06 | 只看該作者
PET Myocardial Perfusion Imaging: 82Rb,e to the diagnostic accuracy over the traditional MPI, quantitative .Rb PET has been widely used to facilitate diagnosis, establish the patient’s workup, and predict successfully outcome in patients with obstructive and nonobstructive CAD. If the oxygen extraction is already maximal in basic conditi
30#
發(fā)表于 2025-3-26 19:41:03 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-19 22:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
湖州市| 巫山县| 广丰县| 织金县| 巴里| 建宁县| 塘沽区| 绥化市| 深圳市| 金山区| 大竹县| 巴东县| 通渭县| 西充县| 天台县| 商洛市| 哈密市| 福海县| 攀枝花市| 白玉县| 锡林浩特市| 铁力市| 普兰店市| 静乐县| 丰都县| 三原县| 读书| 玉田县| 隆德县| 太保市| 兰溪市| 阿勒泰市| 大埔区| 常州市| 东方市| 廉江市| 赫章县| 梁山县| 永州市| 桦甸市| 合水县|